首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

2075119

生物製藥外包市場：按產品類型/服務類型、來源、應用、最終用戶和地區分類

Biologics Outsourcing Market, By Product and Service Type, By Source, By Application By End User, and By Region

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，生物製藥外包市場規模將達到 283.7 億美元，到 2033 年將達到 671.5 億美元。預計 2026 年至 2033 年的複合年成長率將達到 13.1%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	283.7億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	13.10%	2033年市場規模預測：	671.5億美元

生物製藥是指利用天然來源的原料（包括人類、動物或微生物細胞）所生產的藥物，其成分包括碳水化合物、蛋白質或核酸。此外，生物製藥還包括人體細胞和組織、活病毒疫苗、過敏原萃取物以及細胞和基因療法。生物製藥主要用於治療慢性疾病和心血管疾病等。

由於生物製藥產業的快速發展，以及生物製藥公司自身研發和生產能力及體系的不足甚至缺失，製藥公司不得不將生物製藥研發和生產流程的各個環節外包給高效的服務供應商。大型製藥企業將生物製藥的生產外包給合約研究組織（CRO）和合約受託製造廠商（CMO），以降低營運成本，從而專注於自身的核心競爭力。

市場動態

主要市場參與者正專注於非內部成長策略，例如透過合作來強化其產品系列，預計這將推動全球生物製藥外包市場在預測期內的成長。例如，2021年11月，提供端對端CDMO服務的金斯瑞生物科技股份有限公司（GenScript Biotech Corporation）旗下子公司金斯瑞生物科技股份有限公司（GenScript ProBio）宣布，已達成一項協議，用於開發治療性和診斷性單株抗體（mAb）的細胞株，以及生產原料藥和製劑。

主要市場參與者正致力於擴大設施以增強其服務和產品系列，預計將推動全球生物製藥外包市場在預測期內持續成長。例如，2022年12月，製藥公司Catalent宣佈在英國達勒姆（位於北卡羅來納州研究三角區內）開設一家新的生物製藥分析卓越中心，旨在為包括細胞療法和基因療法在內的生物製藥療法提供全面的獨立分析開發和測試服務。該公司計劃投資高達4000萬美元，用於建造這座佔地8萬平方英尺的設施，以安裝包括自動化和數位化功能在內的儀器設備。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究基於以下參數，對全球生物製藥外包市場的主要參與者進行了分析：公司概況、產品系列、關鍵亮點、財務表現和策略。本研究涵蓋的主要參與者包括：賽默飛世爾科技、Abzena、FUJIFILM迪奧新生物技術公司、KBI BioPharma、EirGenix、Curia Global、Bionova Scientific、勃林格殷格翰國際公司、STC Biologics、艾伯維、Avid Bioservices、Catalent、Emergent、Eurofins Scient、生物技術公司、生物技術公司、生物技術公司公司、龍沙、默克集團和Lentzler BioPharma SE。
透過利用本報告中提出的見解，各公司的行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球生物製藥外包市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
相關人員可以透過利用全球生物製藥外包市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

Thermo Fisher Scientific Inc.
Abzena Ltd.
Fujifilm Diosynth Biotechnologies
KBI Biopharma, EirGenix, Inc.
EirGenix, Inc.
Curia Global, Inc.
Bionova Scientific, Inc.
Boehringer Ingelheim International GmbH.
STC Biologics.
Abbvie Inc.
Avid Bioservices, Inc.
Catalent Inc.
Emergent
Eurofins Scientific
Genentech, Inc.
Genscript Biotech Corporation
JSR Corporation
Lonza
Merck KGaA
Rentschler Biopharma SE.

第10章

調查方法
關於本公司

簡介目錄

Product Code: CMI5748

Biologics Outsourcing Market is estimated to be valued at USD 28.37 Bn in 2026 and is expected to reach USD 67.15 Bn by 2033, growing at a compound annual growth rate (CAGR) of 13.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 28.37 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	13.10%	2033 Value Projection:	USD 67.15 Bn

Biologics are the drugs generated from natural sources including human, animal, or microbial cells and consist of carbohydrates, proteins, or nucleic acids. Moreover, biologics include human cells and tissues, live attenuated microbes, allergenic extracts, cell and gene treatments. Biologics medicines are available for the treatment of disease such as chronic disease, cardiovascular disease, and so on.

Pharmaceutical companies had to outsource different stages of the biologic development and manufacturing process to highly effective service provider organizations due to the fast-paced nature of the biologic industry and the insufficient or absence of internal biologic development and manufacturing capabilities and capacities of biopharmaceutical companies. Major pharmaceutical corporations outsource the production of biologics to contract research organizations, contract manufacturing organizations, and others in order to concentrate on their core competencies while reducing operational costs.

Market Dynamics

Key market players are focused on inorganic strategies such as agreements to strengthen its product portfolio, is expected to drive the growth of global biologics outsourcing market over the forecast period. For instance, in November 2021, GenScript ProBio, a subsidiary of GenScript Biotech Corporation offering end-to-end CDMO services, announced that the company had entered into an agreement for cell line development, drug substance, and drug product manufacturing of therapeutic and diagnostic monoclonal antibodies (mAbs).

Key market players is focused on facility expansion to strengthen the company's service and product portfolio, is expected to propel the growth of global biologics outsourcing market over the forecast period. For instance, in December 2022, Catalent, Inc. a pharmaceutical company, announced that it is establishing a new biologics analytical center of excellence in Durham, England, within North Carolina's Research Triangle, to offer comprehensive standalone analytical development and testing for biologic drug modalities, including cell and gene therapies. The company planned to invest up to US$ 40 million to fit the 80,000 square-foot facility with equipment and instrumentation, including automation and digitization capabilities

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global biologics outsourcing market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies. Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Abzena Ltd. Fujifilm Diosynth Biotechnologies, KBI Biopharma, EirGenix, Inc., Curia Global, Inc., Bionova Scientific, Inc., Boehringer Ingelheim International GmbH., STC Biologics., Abbvie Inc., Avid Bioservices, Inc., Catalent Inc., Emergent, Eurofins Scientific, Genentech, Inc., Genscript Biotech Corporation, JSR Corporation, Lonza, Merck KGaA, Rentschler Biopharma SE.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global biologics outsourcing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biologics outsourcing market

Detailed Segmentation:

Global Biologics Outsourcing Market, By (Revenue, USD Bn, 2021 - 2033)Product and Service Type:
Product
- Antibodies
- Recombinant Proteins
- Vaccines
- Others
Services
- Cell Development
- Process Development
- Analytical Testing
- cGMP Manufacturing
- Others
Global Biologics Outsourcing Market, By Source (Revenue, USD Bn, 2021 - 2033)
Mammalian
Microbial
Global Biologics Outsourcing Market By Application:
Oncology
Cellular and Gene Therapy
Blood & Blood-Related Products Development
Vaccine Development
Stem Cell Research
Others
Global Biologics Outsourcing Market By End User:
Pharmaceutical Industries
Biotechnology Industries
CDMO
Global Biologics Outsourcing Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- By Country:
  - U.S.
  - Canada
Latin America
- By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- By Country:
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- By Country:
  - GCC
  - Israel
  - Rest of Middle East
Africa
- By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
Thermo Fisher Scientific Inc.*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Abzena Ltd.
Fujifilm Diosynth Biotechnologies
KBI Biopharma,
EirGenix, Inc.
Curia Global, Inc.
Bionova Scientific, Inc.
Boehringer Ingelheim International GmbH.
STC Biologics.
Abbvie Inc.
Avid Bioservices, Inc.
Catalent Inc.
Emergent
Eurofins Scientific
Genentech, Inc.
Genscript Biotech Corporation
JSR Corporation
Lonza
Merck KGaA
Rentschler Biopharma SE.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product and Service Type
- Market Snapshot, By Source
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- Technology Landscape
- Service Cost Analysis

4. Global Biologics Outsourcing Market, By Product and Service Type, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Product
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  - Antibodies
  - Recombinant Proteins
  - Vaccines
  - Others
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  - Cell Development
  - Process Development
  - Analytical Testing
  - cGMP Manufacturing
  - Others

5. Global Biologics Outsourcing Market, By Source, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Mammalian
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Microbial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

6. Global Biologics Outsourcing Market, By Application, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Cellular and Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Blood & Blood-Related Products Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Vaccine Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Stem Cell Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

7. Global Biologics Outsourcing Market, By End User, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segments Trends
Pharmaceutical Industries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Biotechnology Industries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
CDMO
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

8. Global Biologics Outsourcing Market, By Region, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Service Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Service Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Service Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Service Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Service Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Service Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Abzena Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Fujifilm Diosynth Biotechnologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
KBI Biopharma, EirGenix, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
EirGenix, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Curia Global, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bionova Scientific, Inc.
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Boehringer Ingelheim International GmbH.
- Company Highlights
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
STC Biologics.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Abbvie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Avid Bioservices, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Catalent Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Emergent
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Genentech, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Genscript Biotech Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
JSR Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Lonza
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Rentschler Biopharma SE.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies